Dong Sung Bio Pharm.Co.,Ltd. (KRX: 002210)

Dong Sung Bio Pharm.Co.,Ltd. Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Oct 10, 2024	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Market Capitalization	104,040	24,633	24,810	26,238	21,826	36,502
Market Cap Growth	13.52%	-0.71%	-5.45%	20.22%	-40.21%	54.87%
Enterprise Value	40,658	40,658	42,182	43,804	36,221	56,080
Last Close Price	4550.00	1371.34	1351.36	1359.95	1080.35	1914.43
PE Ratio	47.23	14.24	-3.10	43.44	5.36	12.54
PS Ratio	1.02	0.31	0.34	0.38	0.35	0.61
PB Ratio	1.33	0.41	0.42	0.39	0.32	0.79
P/FCF Ratio	-8.15	-8.15	8.74	-4.57	-27.90	30.36
P/OCF Ratio	-9.32	-9.32	6.73	-5.23	-59.75	12.51
EV/Sales Ratio	0.52	0.52	0.59	0.64	0.58	0.93
EV/EBITDA Ratio	8.82	8.82	-26.38	18.10	12.61	18.56
EV/EBIT Ratio	13.10	13.10	-13.57	39.66	24.38	36.05
EV/FCF Ratio	-13.45	-13.45	14.87	-7.63	-46.30	46.65
Debt / Equity Ratio	0.58	0.58	0.57	0.46	0.40	0.68
Debt / EBITDA Ratio	7.57	7.57	-	12.93	9.42	10.39
Debt / FCF Ratio	-11.55	-11.55	11.87	-5.45	-34.56	26.10
Asset Turnover	0.62	0.62	0.56	0.54	0.55	0.60
Inventory Turnover	3.06	3.06	2.83	2.47	2.49	2.42
Quick Ratio	1.18	1.18	1.20	1.39	1.61	1.49
Current Ratio	1.47	1.47	1.45	1.74	2.02	1.81
Return on Equity (ROE)	2.85%	2.85%	-12.36%	0.84%	6.42%	6.04%
Return on Assets (ROA)	1.54%	1.54%	-1.52%	0.55%	0.81%	0.96%
Return on Capital (ROIC)	2.06%	2.06%	-2.02%	0.71%	1.08%	1.29%
Earnings Yield	2.12%	6.91%	-31.66%	2.17%	16.75%	7.28%
FCF Yield	-2.91%	-12.28%	11.44%	-21.89%	-3.58%	3.29%
Dividend Yield	2.19%	2.19%	-	2.21%	2.78%	1.57%
Payout Ratio	31.14%	31.14%	-	95.83%	14.90%	25.81%
Buyback Yield / Dilution	2.59%	1.98%	0.79%	-	-4.39%	11.41%
Total Shareholder Return	2.59%	4.17%	0.79%	2.21%	-1.61%	12.98%

Source: S&P Capital IQ. Standard template. Financial Sources.